TGTX: TG Therapeutics Inc
TGTX exchange rate has changed by -0.40% for today. During the day, the instrument was traded at a low of 42.26 and at a high of 44.65.
Follow TG Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TGTX News
- Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
- Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review
- Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More
- TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View
- Dow Jones Futures: Stock Market Hits Highs On Iran-Deal Hopes, Nvidia Leads New Buys; ARM Is Big Earnings Mover
- TG Therapeutics (TGTX) Q1 Earnings Lag Estimates
- Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
- TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth
- TG Therapeutics Stock: Flawless Execution $500M Non-Dilutive Boost Outlook (NASDAQ:TGTX)
- TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
- Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?
- TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX)
- BRIUMVI shows efficacy in highly active multiple sclerosis patients
- TG Therapeutics to present BRIUMVI data at neurology meeting
- TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
- TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
- TG earnings missed by $0.23, revenue topped estimates
- Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
- TG Therapeutics faces earnings test as Briumvi growth accelerates
- TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
- TG Therapeutics presents BRIUMVI data at ACTRIMS forum
- TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
Frequently Asked Questions
What is TGTX stock price today?
TG Therapeutics Inc stock is priced at 42.86 today. It trades within 42.26 - 44.65, yesterday's close was 43.03, and trading volume reached 8725. The live price chart of TGTX shows these updates.
Does TG Therapeutics Inc stock pay dividends?
TG Therapeutics Inc is currently valued at 42.86. Dividend policy depends on the company, while investors also watch 22.28% and USD. View the chart live to track TGTX movements.
How to buy TGTX stock?
You can buy TG Therapeutics Inc shares at the current price of 42.86. Orders are usually placed near 42.86 or 43.16, while 8725 and -0.37% show market activity. Follow TGTX updates on the live chart today.
How to invest into TGTX stock?
Investing in TG Therapeutics Inc involves considering the yearly range 26.76 - 44.65 and current price 42.86. Many compare 26.58% and 30.95% before placing orders at 42.86 or 43.16. Explore the TGTX price chart live with daily changes.
What are TG Therapeutics Inc stock highest prices?
The highest price of TG Therapeutics Inc in the past year was 44.65. Within 26.76 - 44.65, the stock fluctuated notably, and comparing with 43.03 helps spot resistance levels. Track TG Therapeutics Inc performance using the live chart.
What are TG Therapeutics Inc stock lowest prices?
The lowest price of TG Therapeutics Inc (TGTX) over the year was 26.76. Comparing it with the current 42.86 and 26.76 - 44.65 shows potential long-term entry points. Watch TGTX moves on the chart live for more details.
When did TGTX stock split?
TG Therapeutics Inc has gone through stock splits historically. These changes are visible in , 43.03, and 22.28% after corporate actions.
- Previous Close
- 43.03
- Open
- 43.02
- Bid
- 42.86
- Ask
- 43.16
- Low
- 42.26
- High
- 44.65
- Volume
- 8.725 K
- Daily Change
- -0.40%
- Month Change
- 26.58%
- 6 Months Change
- 30.95%
- Year Change
- 22.28%